✳flâneur — a map of the web's best reading

History of Women’s Participation in Clinical Research | Office of Research on Women's Health

orwh.od.nih.gov · 866 words · saved by 1 readers

Policies that encourage the inclusion of women in research originated during the women’s health movement, which emerged as part of the women’s movement. During the 1970s, few women worked in either medicine or science, and many women believed that women’s health needs were a low priority in the scientific and medical fields. In 1977, a Food and Drug Administration policy recommended excluding women of childbearing potential from Phase I and early Phase II drug trials.1 The policy was broad and recommended excluding even women who used contraception, who were single, or whose husbands were vasectomized.2 This cautious approach resulted from drug-related incidents, particularly the tragedy that occurred from the use of the drug thalidomide. Thalidomide was a sedative that was never approved for use in the United States. However, the drug was used widely throughout Europe and Canada. Thousands of women who took the drug while pregnant gave birth to babies with horrible limb deformities. T

History of Women’s Participation in Clinical Research Policies that encourage the inclusion of women in research originated during the women’s health movement, which emerged as part of the women’s movement. During the 1970s, few women worked in either medicine or science, and many women believed that women’s health needs were a low priority in the scientific and medical fields. Caution About Allowing Women to Participate in Drug Trials In 1977, a Food and Drug Administration policy recommended excluding women of childbearing potential from Phase I and early Phase II drug trials. The policy was

Explore this link on the map →

saved by

related reading